Characteristic | Sepsis-3 positivea/Sepsis-2 positive (n = 341) | Sepsis-3 negative/Sepsis-2 positive (n = 70) | Sepsis-3 positive/Sepsis-2 negative (n = 16) | Sepsis-3 negative/Sepsis-2 negative (n = 87) |
---|---|---|---|---|
Microbiological findings, n (%) | ||||
BSI episodes with clinically relevant growth | 124 (36.4) | 21 (30.0) | 6 (37.5) | 7 (8.0) |
Contaminated episodes | 29 (8.5) | 6 (8.6) | 1 (6.3) | 8 (9.2) |
Episodes with G+ isolates | 57 (16.7) | 7 (10.0) | 4 (25.0) | 2 (2.3) |
Episodes with G− isolates | 79 (23.2) | 14 (20.0) | 2 (12.5) | 4 (4.6) |
Fungal isolates | 1 (0.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Episodes with anaerobic isolates | 7 (2.1) | 3 (4.3) | 0 (0.0) | 1 (1.1) |
Time to detection (h)b | 16.5 (11.6) | 25.5 (22.4) | 13.9 (6.0) | 26.2 (13.5) |